Defining resectability of colorectal liver metastases: how and why?

Author： Voorthuizen Theo van   van Gulik Thomas M   Punt Cornelis JA  

Publisher： Future Medicine

ISSN： 1758-194X

Source： Colorectal Cancer, Vol.2, Iss.1, 2013-02, pp. : 61-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How can we improve the quality of reporting family history in colorectal cancer care? (And why does it matter?)

By Wilson Brenda J  

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 99-102

Future Medicine

Access to resources Recommend Favorite

Which women aren’t getting mammograms and why? (United States)

By Meissner Helen   Breen Nancy   Taubman Michele   Vernon Sally   Graubard Barry  

Cancer Causes and Control, Vol. 18, Iss. 1, 2007-02 ,pp. : 61-70

Springer Publishing Company

Access to resources Recommend Favorite

Extramedullary multiple myeloma: extraosseous relapse is extra “bad news,“ but why?

By Moreau Philippe  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1349-1350

Informa Healthcare

Access to resources Recommend Favorite

Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement

By Abdalla Eddie   Adam René   Bilchik Anton   Jaeck Daniel   Vauthey Jean-Nicolas   Mahvi David  

Annals of Surgical Oncology, Vol. 13, Iss. 10, 2006-10 ,pp. : 1271-1280

Springer Publishing Company

Access to resources Recommend Favorite

How do we optimally use cetuximab in first-line treatment for metastatic colorectal cancer?

By Lindsay Colin R   Roxburgh Patricia   Graham Janet  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 825-829

Future Medicine

Access to resources Recommend Favorite